Ayala Pharmaceuticals, Inc is a biotechnology business based in the US. Ayala Pharmaceuticals shares (AYLA) are listed on the NASDAQ and all prices are listed in US Dollars. Ayala Pharmaceuticals employs 34 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Ayala Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AYLA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Ayala Pharmaceuticals stock price (NASDAQ: AYLA)Use our graph to track the performance of AYLA stocks over time.
Ayala Pharmaceuticals shares at a glance
|Latest market close||$9.54|
|52-week range||$7.74 - $23.99|
|50-day moving average||$10.61|
|200-day moving average||$12.01|
|Wall St. target price||$22.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy Ayala Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Ayala Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ayala Pharmaceuticals price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||4.15%|
|3 months (2021-04-30)||-10.25%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Ayala Pharmaceuticals financials
|Revenue TTM||$3.7 million|
|Gross profit TTM||$1 million|
|Return on assets TTM||-54.72%|
|Return on equity TTM||-108.25%|
|Market capitalisation||$154.9 million|
TTM: trailing 12 months
Shorting Ayala Pharmaceuticals shares
There are currently 152,989 Ayala Pharmaceuticals shares held short by investors – that's known as Ayala Pharmaceuticals's "short interest". This figure is 8.5% up from 141,054 last month.
There are a few different ways that this level of interest in shorting Ayala Pharmaceuticals shares can be evaluated.
Ayala Pharmaceuticals's "short interest ratio" (SIR)
Ayala Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Ayala Pharmaceuticals shares currently shorted divided by the average quantity of Ayala Pharmaceuticals shares traded daily (recently around 40688.563829787). Ayala Pharmaceuticals's SIR currently stands at 3.76. In other words for every 100,000 Ayala Pharmaceuticals shares traded daily on the market, roughly 3760 shares are currently held short.
However Ayala Pharmaceuticals's short interest can also be evaluated against the total number of Ayala Pharmaceuticals shares, or, against the total number of tradable Ayala Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ayala Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ayala Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0328% of the tradable shares (for every 100,000 tradable Ayala Pharmaceuticals shares, roughly 33 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ayala Pharmaceuticals.
Find out more about how you can short Ayala Pharmaceuticals stock.
Ayala Pharmaceuticals share dividends
We're not expecting Ayala Pharmaceuticals to pay a dividend over the next 12 months.
Ayala Pharmaceuticals overview
Ayala Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, which is an intravenous injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, an oral injectable small molecule GSI that is in Phase I clinical trial for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.
Stocks similar to Ayala Pharmaceuticals
Ayala Pharmaceuticals in the news
We Think Ayala Pharmaceuticals (NASDAQ:AYLA) Needs To Drive Business Growth Carefully
Ayala's Stock Surges After Ladenburg Initiates Coverage With Price Target Of $29
Ayala's Stock Surges After Ladenburg Initiates Coverage With Price Target Of $29
Frequently asked questionsWhat percentage of Ayala Pharmaceuticals is owned by insiders or institutions?
Currently 54.221% of Ayala Pharmaceuticals shares are held by insiders and 15.457% by institutions. How many people work for Ayala Pharmaceuticals?
Latest data suggests 34 work at Ayala Pharmaceuticals. When does the fiscal year end for Ayala Pharmaceuticals?
Ayala Pharmaceuticals's fiscal year ends in December. Where is Ayala Pharmaceuticals based?
Ayala Pharmaceuticals's address is: 4 Oppenheimer Street, Rehovot, Israel, 7670104 What is Ayala Pharmaceuticals's ISIN number?
Ayala Pharmaceuticals's international securities identification number is: US05465V1089 What is Ayala Pharmaceuticals's CUSIP number?
Ayala Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 05465V108
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert